FDA Drug Recalls

Recalls / Class I

Class ID-1299-2020

Class I— FDA's most serious classification, issued when there is a reasonable probability that use of or exposure to the drug will cause serious adverse health consequences or death.

Product

NP Thyroid 60, Thyroid Tablets, USP, 1 grain (60 mg), 100-count bottles, Rx Only, Manufactured For: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, NDC 42192-330-01.

Brand name
Np Thyroid 15
Generic name
Levothyroxine, Liothyronine
Active ingredients
Levothyroxine, Liothyronine
Route
Oral
NDCs
42192-327, 42192-329, 42192-330, 42192-331, 42192-328
Affected lot / code info
Lots: M330J18-2A, M330J18-3 Exp. AUG-2020

Why it was recalled

Superpotent Drug.

Recalling firm

Firm
Acella Pharmaceuticals, LLC
Notification channel
Press Release
Type
Voluntary: Firm initiated
Address
1880 Mcfarland Pkwy Ste 110-B, N/A, Alpharetta, Georgia 30005

Distribution

Quantity
29,304 bottles
Distribution pattern
Distributed Nationwide in the US and Puerto Rico

Timeline

Recall initiated
2020-05-22
FDA classified
2020-06-08
Posted by FDA
2020-06-10
Terminated
2022-01-19
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1299-2020. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.